ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,688Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 120

$533K Total Retail Price of All Prescriptions

Rank: 31 out of 120

677 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Montana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 677 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 677 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 690 601 149 1 2
LISINOPRIL 656 611 150 2 3
OMEPRAZOLE 527 467 115 3 4
HYDROCHLOROTHIAZIDE 478 431 125 4 10
HYDROCODONE-ACETAMINOPHEN 438 322 91 S3 5 7
AMLODIPINE BESYLATE 434 408 91 6 5
LEVOTHYROXINE SODIUM 432 408 89 7 1
ATENOLOL 351 314 71 8 18
MELOXICAM 334 297 82 9 44
WARFARIN SODIUM 290 285* 57 10 8
CITALOPRAM HBR 281 266 48 11 17
METOPROLOL SUCCINATE 276 263 56 12 13
ATORVASTATIN CALCIUM 250 235 59 13 9
GABAPENTIN 217 170 43 14 16
FUROSEMIDE 211 196 48 15 6
LORAZEPAM 207 168 38 B 16 21
LOSARTAN POTASSIUM 207 202* 49 16 11
METOPROLOL TARTRATE 204 199* 35 18 15
METFORMIN HCL 165 141 36 19 14
ALENDRONATE SODIUM 153 148* 35 20 27
TAMSULOSIN HCL 151 138 33 21 24
FLUOXETINE HCL 143 127 28 22 35
POTASSIUM CHLORIDE 137 132* 32 23 12
POLYETHYLENE GLYCOL 3350 136 117 31 24 79
ZOLPIDEM TARTRATE 122 117* 36 25 22
PRAVASTATIN SODIUM 117 112* 20 26 23
BENAZEPRIL HCL 114 88 27 27 47
CLONAZEPAM 113 81 18 B 28 42
ALLOPURINOL 111 106* 24 29 19
PREDNISONE 110 105* 30 30 33
PAROXETINE HCL 107 61 15 31 55
FLUTICASONE PROPIONATE 83 72 29 32 36
TRAMADOL HCL 80 43 15 33 26
DOXAZOSIN MESYLATE 76 71* 20 34 56
PANTOPRAZOLE SODIUM 75 70* 18 35 41
TRAZODONE HCL 74 69* 20 36 37
DONEPEZIL HCL 74 61 12 36 39
MORPHINE SULFATE ER 68 <11 <11 S2 38 71
EVISTA 68 68 13 38 118
CIPROFLOXACIN HCL 65 60* 51 40 84
METHADONE HCL 64 <11 <11 S2 41 110
SPIRONOLACTONE 64 59* 13 41 34
TRIAMTERENE-HCTZ 61 61 13 43 29
BUPROPION HCL SR 61 <11 <11 43 185
LANTUS SOLOSTAR 61 46 16 43 50
VENLAFAXINE HCL ER 59 <11 <11 46 53
AMITRIPTYLINE HCL 59 54* 12 R 46 66
VENTOLIN HFA 59 54* 17 46 99
LOVASTATIN 59 59 16 46 60
FENTANYL 59 <11 <11 S2 46 48
ACETAMINOPHEN-CODEINE 57 57 12 S3 51 137
CYMBALTA 56 <11 <11 52 30
ADVAIR DISKUS 55 50* 16 53 31
CLOPIDOGREL 54 54 12 54 28
GEMFIBROZIL 52 33 12 55 75
SPIRIVA 51 <11 <11 56 58
ALPRAZOLAM 50 38 17 B 57 46
CARVEDILOL 50 45* 13 57 25
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.